Wearlinq provides a wearable ECG monitoring device to detect heart disorders, offering continuous monitoring of heart rate to detect conditions like atrial fibrillation, tachycardia, and arrhythmia. The device connects with an app for prior alerts on abnormal conditions and ECG visualization, with sharing capabilities for practitioners. Founded in 2019 in Stanford, United States, the company has raised $26.3M in Series A funding from investors including AIX Ventures, Lightscape, and Amino Capital. The hardware device helps in continuous monitoring of a patient's heart rate to detect conditions like atrial fibrillation, tachycardia, and other arrhythmia disorders. The device is connected with the app to get prior alerts on abnormal conditions and also to visualize the ECG signals.
Wearlinq
Series AWearlinq provides a wearable ECG monitoring device to detect heart disorders, offering continuous monitoring of heart rate to detect conditions like atrial fibrillation, tachycardia, and arrhythmia. The device connects with an app for prior alerts on abnormal conditions and ECG visualization, with sharing capabilities for practitioners. Founded in 2019 in Stanford, United States, the company has raised $26.3M in…
About
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device > Wearable,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology > Wearable > ECG Patch,
Cardiac and Vascular Disorders > In-Vitro Diagnostics > Arrhythmia
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.